Remove 2022 Remove Clinic Remove Disease Remove Radiation
article thumbnail

Cardiac PET use increases in coronary artery disease

AuntMinnie

PET, CT, and MRI use for assessing coronary artery disease increased in Medicare patients from 2018 to 2022, while SPECT and stress echocardiography declined over the same period, researchers have reported. Taken together, these findings call for efforts to address barriers impeding wider uptake of PET,” the group wrote.

Disease 89
article thumbnail

ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

Imaging Technology

The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Liquid Biopsy May Help Identify Which Patients with Non-small Cell Lung Cancer Will Benefit Most from Radiation

Imaging Technology

milla1cf Mon, 10/02/2023 - 13:30 October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. and worldwide. Chaudhuri explained.

article thumbnail

Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance New Combination Therapy Challenge Announced

Imaging Technology

milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.

Radiation 105
article thumbnail

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the analysis of Neuromelanin-sensitive MRI

Imaging Technology

We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades.

article thumbnail

Road to RSNA 2023: Digital X-Ray

AuntMinnie

Louis asked, “How much ionizing radiation are neonatal patients exposed to during interventional procedures?” You can also view the complete 2022 scientific and educational program on the RSNA 2023 website. Radiation doses estimated in infants with congenital heart disease Monday, November 27 | 3:10 p.m.-3:20 1:10 p.m. |

X-ray 114
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.